Bessemer Group Inc Argenx Se Transaction History
Bessemer Group Inc
- $61.6 Billion
- Q2 2025
A detailed history of Bessemer Group Inc transactions in Argenx Se stock. As of the latest transaction made, Bessemer Group Inc holds 17 shares of ARGX stock, worth $10,838. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 17
-0.0%
Holding current value
$10,838
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARGX
# of Institutions
498Shares Held
28.6MCall Options Held
331KPut Options Held
226K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.43 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.78 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.37 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.24 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$787 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...